Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical management — Alexander Valent (2013) | RDL Network
Change in HER2 (ERBB2) gene status after taxane-based chemotherapy for breast cancer: polyploidization can lead to diagnostic pitfalls with potential impact for clinical management
Marta Rossi, Greta Carioli, Martina Bonifazi, Alberto Zambelli, Matteo Franchi, Lorenzo Moja, Antonella Zambon, Giovanni Corrao, Carlo La Vecchia, Carlo Zocchetti, Eva Negri
Discussion(0)
No comments yet. Be the first to comment.